Application and prospect of organoids-on-chip in the study of nano-drug delivery systems

被引：0
|
作者：
Yang Y. [1 ]
Li M. [1 ]
Yao Z. [1 ]
Sun Q. [1 ]
Liu Y. [1 ]
Ge D. [1 ]
Sun B. [1 ]
机构：
[1] School of Chemical Engineering, Dalian University of Technology, Liaoning, Dalian
来源：
Huagong Xuebao/CIESC Journal | 2024年 / 75卷 / 04期
关键词：
cell biology; drug delivery; nanomaterials; organoids-on-chip; tissue engineering;
D O I：
10.11949/0438-1157.20231262
中图分类号：
学科分类号：
摘要：
Organoids are self-assembling three-dimensional multicellular structures derived from human stem cells, organ-specific progenitor cells or isolated tumor tissues, which could reproduce the key structural features and physiological functions of organs in vitro. As an in vitro culture platform for organoids, microfluidic chips provide opportunities to study the behavior of cells in heterogeneous populations and microenvironments. Therefore, they have become a powerful tool to assist human organ development research, disease modeling, and drug screening. Nanomaterials, as an advanced carrier for drug delivery, can significantly improve the therapeutic effects of drugs and have become the focus of new drug development. Organoids-on-chip not only provide a reliable platform for evaluating the safety and efficacy of nano-drug delivery systems, but also help the design of nanocarriers and personalized treatment. In this review, we give an update on the limitations of traditional two-dimensional cell models and animal models in nano-drug delivery systems evaluation, with an emphasis on the advantages of in vitro platforms by organoids-on-chip. It also summarized the recent application and development of organoids technology and future directions in nano-drug delivery systems. © 2024 Materials China. All rights reserved.
引用
收藏
页码：1209 / 1221
页数：12
相关论文
共 122 条
  • [1] Liu J Y, Li S Q, Wang J, Et al., Application of nano drug delivery system (NDDS) in cancer therapy: a perspective, Recent Patents on Anti-Cancer Drug Discovery, 18, 2, pp. 125-132, (2022)
  • [2] Sun M C, Xu X L, Lou X F, Et al., Recent progress and future directions: the nano-drug delivery system for the treatment of vitiligo, International Journal of Nanomedicine, 15, pp. 3267-3279, (2020)
  • [3] Wang C D, Li F S, Zhang T A, Et al., Recent advances in anti-multidrug resistance for nano-drug delivery system, Drug Delivery, 29, 1, pp. 1684-1697, (2022)
  • [4] Zhang Y, Wu Y J, Du H J, Et al., Nano-drug delivery systems in oral cancer therapy: recent developments and prospective, Pharmaceutics, 16, 1, (2023)
  • [5] Mu W W, Chu Q H, Liu Y J, Et al., A review on nano-based drug delivery system for cancer chemoimmunotherapy, Nano-Micro Letters, 12, 1, (2020)
  • [6] Kapalczynska M, Kolenda T, Przybyla W, Et al., 2D and 3D cell cultures—a comparison of different types of cancer cell cultures, Archives of Medical Science, 14, 4, pp. 910-919, (2018)
  • [7] Bao Y L, Wang L, Pan H T, Et al., Animal and organoid models of liver fibrosis, Frontiers in Physiology, 12, (2021)
  • [8] Jiang X J, Ouyang L, Peng Q, Et al., Organoids: opportunities and challenges of cancer therapy, Frontiers in Cell and Developmental Biology, 11, (2023)
  • [9] Wang H, Ning X F, Zhao F, Et al., Human organoids-on-chips for biomedical research and applications[J], Theranostics, 14, 2, pp. 788-818, (2024)
  • [10] Khan A U, Khan M, Cho M H, Et al., Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure, Bioprocess and Biosystems Engineering, 43, 8, pp. 1339-1357, (2020)
12345678910